重组活化因子VII在小儿患者严重出血治疗中的应用 - Suppr

Suppr

超能文献

[Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].

作者信息

Veyckemans F

机构信息

Service d'Anesthésiologie, Cliniques Universitaires St-Luc, 1200 Bruxelles, Belgique.

出版信息

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):676-7. doi: 10.1016/j.annfar.2009.06.006. Epub 2009 Jul 1.

DOI:10.1016/j.annfar.2009.06.006

PMID:19574019

Abstract

摘要

相似文献

[Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):676-7. doi: 10.1016/j.annfar.2009.06.006. Epub 2009 Jul 1.

Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

Can J Anaesth. 2002 Dec;49(10):S7-14.

Recombinant factor VIIa: a review on its clinical use.

Int J Hematol. 2006 Feb;83(2):126-38. doi: 10.1532/IJH97.E0517.

[Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation].

Ann Fr Anesth Reanim. 2006 Jan;25(1):2-5. doi: 10.1016/j.annfar.2005.09.005. Epub 2005 Dec 27.

NovoSeven for non-hemophilia hemostasis.

Med Lett Drugs Ther. 2004 Apr 26;46(1181):33-4.

Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.

Thromb Haemost. 1998 Jul;80(1):204-5.

rFVIIa (Novoseven): the new panacea?

Acta Anaesthesiol Belg. 2003;54(4):333-5.

[Use of activated recombinant FVII in the control of haemorrhage following trauma].

Ann Fr Anesth Reanim. 2006 Sep;25(9):990-3. doi: 10.1016/j.annfar.2006.05.007. Epub 2006 Aug 22.

[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].

Med Klin (Munich). 2007 Jan 15;102(1):70-81. doi: 10.1007/s00063-007-1012-9.

Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.

Am J Hematol. 2002 Aug;70(4):333. doi: 10.1002/ajh.10164.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].

作者信息

Veyckemans F

机构信息

Service d'Anesthésiologie, Cliniques Universitaires St-Luc, 1200 Bruxelles, Belgique.

出版信息

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):676-7. doi: 10.1016/j.annfar.2009.06.006. Epub 2009 Jul 1.

DOI:10.1016/j.annfar.2009.06.006

PMID:19574019

Abstract

摘要

相似文献

[Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):676-7. doi: 10.1016/j.annfar.2009.06.006. Epub 2009 Jul 1.

Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

Can J Anaesth. 2002 Dec;49(10):S7-14.

Recombinant factor VIIa: a review on its clinical use.

Int J Hematol. 2006 Feb;83(2):126-38. doi: 10.1532/IJH97.E0517.

[Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation].

Ann Fr Anesth Reanim. 2006 Jan;25(1):2-5. doi: 10.1016/j.annfar.2005.09.005. Epub 2005 Dec 27.

NovoSeven for non-hemophilia hemostasis.

Med Lett Drugs Ther. 2004 Apr 26;46(1181):33-4.

Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.

Thromb Haemost. 1998 Jul;80(1):204-5.

rFVIIa (Novoseven): the new panacea?

Acta Anaesthesiol Belg. 2003;54(4):333-5.

[Use of activated recombinant FVII in the control of haemorrhage following trauma].

Ann Fr Anesth Reanim. 2006 Sep;25(9):990-3. doi: 10.1016/j.annfar.2006.05.007. Epub 2006 Aug 22.

[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].

Med Klin (Munich). 2007 Jan 15;102(1):70-81. doi: 10.1007/s00063-007-1012-9.

Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.

Am J Hematol. 2002 Aug;70(4):333. doi: 10.1002/ajh.10164.